🔴 Roivant Sciences is trading 5% down in pre-market

Roivant Sciences is trading down 5.06% in pre-market at $32.99 on October 8, with no clear company-specific announcement identified as the cause.

• It closed at $34.75 on October 7.
• Supplied market data shows U.S. futures lower; reports cite elevated Treasury yields weighing on equities, but the provided index declines are below 0.5%.
• The recent $950 million Moderna settlement and positive Phase 2 NEPTUNE results are earlier news, not confirmed explanations for this morning’s drop.